{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:23:30Z","timestamp":1791149010647,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10456-017-9549-6","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T07:34:56Z","timestamp":1491550496000},"page":"233-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists"],"prefix":"10.1007","volume":"20","author":[{"given":"MariaRosa","family":"Bani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Decio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Giavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ghilardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"9549_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrd3870","volume":"12","author":"DW McMillin","year":"2013","unstructured":"McMillin DW, Negri JM, Mitsiades CS (2013) The role of tumour\u2013stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov 12:217\u2013228. doi:\n                        10.1038\/nrd3870","journal-title":"Nat Rev Drug Discov"},{"key":"9549_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1124\/pr.114.010215","volume":"67","author":"JR Beijnum van","year":"2015","unstructured":"van Beijnum JR, Nowak-Sliwinska P, Huijbers EJM et al (2015) The great escape; the hallmarks of resistance to antiangiogenic therapy. Pharmacol Rev 67:441\u2013461. doi:\n                        10.1124\/pr.114.010215","journal-title":"Pharmacol Rev"},{"key":"9549_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drup.2016.02.002","volume":"25","author":"EJM Huijbers","year":"2016","unstructured":"Huijbers EJM, van Beijnum JR, Thijssen VL et al (2016) Role of the tumor stroma in resistance to anti-angiogenic therapy. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother 25:26\u201337. doi:\n                        10.1016\/j.drup.2016.02.002","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"key":"9549_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-0030-1253454","volume":"36","author":"JA Nagy","year":"2010","unstructured":"Nagy JA, Chang S-H, Shih S-C et al (2010) Heterogeneity of the tumor vasculature. Semin Thromb Hemost 36:321\u2013331. doi:\n                        10.1055\/s-0030-1253454","journal-title":"Semin Thromb Hemost"},{"key":"9549_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"C-H Heldin","year":"2004","unstructured":"Heldin C-H, Rubin K, Pietras K, Ostman A (2004) High interstitial fluid pressure\u2014an obstacle in cancer therapy. Nat Rev Cancer 4:806\u2013813. doi:\n                        10.1038\/nrc1456","journal-title":"Nat Rev Cancer"},{"key":"9549_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jb\/mvs152","volume":"153","author":"K Hida","year":"2013","unstructured":"Hida K, Akiyama K, Ohga N et al (2013) Tumour endothelial cells acquire drug resistance in a tumour microenvironment. J Biochem (Tokyo) 153:243\u2013249. doi:\n                        10.1093\/jb\/mvs152","journal-title":"J Biochem (Tokyo)"},{"key":"9549_CR7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1023\/A:1006738901839","volume":"17","author":"G Alessandri","year":"1999","unstructured":"Alessandri G, Chirivi RG, Fiorentini S et al (1999) Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells. Clin Exp Metastas 17:655\u2013662","journal-title":"Clin Exp Metastas"},{"key":"9549_CR8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/157016110790887036","volume":"8","author":"B Bussolati","year":"2010","unstructured":"Bussolati B, Deregibus MC, Camussi G (2010) Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies. Curr Vasc Pharmacol 8:220\u2013232","journal-title":"Curr Vasc Pharmacol"},{"key":"9549_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00018-011-0862-8","volume":"69","author":"A Silini","year":"2012","unstructured":"Silini A, Ghilardi C, Figini S et al (2012) Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor\u2019s proangiogenic microenvironment. Cell Mol Life Sci CMLS 69:1167\u20131178. doi:\n                        10.1007\/s00018-011-0862-8","journal-title":"Cell Mol Life Sci CMLS"},{"key":"9549_CR10","doi-asserted-by":"publisher","first-page":"28389","DOI":"10.18632\/oncotarget.4949","volume":"6","author":"C Ghilardi","year":"2015","unstructured":"Ghilardi C, Silini A, Figini S et al (2015) Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2. Oncotarget 6:28389\u201328400. doi:\n                        10.18632\/oncotarget.4949","journal-title":"Oncotarget"},{"key":"9549_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s10147-016-0957-1","volume":"21","author":"K Hida","year":"2016","unstructured":"Hida K, Maishi N, Torii C, Hida Y (2016) Tumor angiogenesis\u2014characteristics of tumor endothelial cells. Int J Clin Oncol 21:206\u2013212. doi:\n                        10.1007\/s10147-016-0957-1","journal-title":"Int J Clin Oncol"},{"key":"9549_CR12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","volume":"289","author":"B St Croix","year":"2000","unstructured":"St Croix B, Rago C, Velculescu V et al (2000) Genes expressed in human tumor endothelium. Science 289:1197\u20131202","journal-title":"Science"},{"key":"9549_CR13","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1158\/0008-5472.CAN-06-3700","volume":"67","author":"C Lu","year":"2007","unstructured":"Lu C, Bonome T, Li Y et al (2007) Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer Res 67:1757\u20131768. doi:\n                        10.1158\/0008-5472.CAN-06-3700","journal-title":"Cancer Res"},{"key":"9549_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ccr.2007.04.017","volume":"11","author":"S Seaman","year":"2007","unstructured":"Seaman S, Stevens J, Yang MY et al (2007) Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11:539\u2013554. doi:\n                        10.1016\/j.ccr.2007.04.017","journal-title":"Cancer Cell"},{"key":"9549_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1471-2164-9-201","volume":"9","author":"C Ghilardi","year":"2008","unstructured":"Ghilardi C, Chiorino G, Dossi R et al (2008) Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium. BMC Genom 9:201. doi:\n                        10.1186\/1471-2164-9-201","journal-title":"BMC Genom"},{"key":"9549_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1096\/fj.02-0557fje","volume":"17","author":"B Bussolati","year":"2003","unstructured":"Bussolati B, Deambrosis I, Russo S et al (2003) Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J Off Publ Fed Am Soc Exp Biol 17:1159\u20131161. doi:\n                        10.1096\/fj.02-0557fje","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"9549_CR17","first-page":"381","volume":"15","author":"C Grange","year":"2006","unstructured":"Grange C, Bussolati B, Bruno S et al (2006) Isolation and characterization of human breast tumor-derived endothelial cells. Oncol Rep 15:381\u2013386","journal-title":"Oncol Rep"},{"key":"9549_CR18","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1158\/1078-0432.CCR-08-2780","volume":"15","author":"Y-Q Xiong","year":"2009","unstructured":"Xiong Y-Q, Sun H-C, Zhang W et al (2009) Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin Cancer Res Off J Am Assoc Cancer Res 15:4838\u20134846. doi:\n                        10.1158\/1078-0432.CCR-08-2780","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"9549_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13:714\u2013726. doi:\n                        10.1038\/nrc3599","journal-title":"Nat Rev Cancer"},{"key":"9549_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1309\/L44X-L5DN-1VHV-X30N","volume":"117","author":"FD Camassei","year":"2002","unstructured":"Camassei FD, Arancia G, Cianfriglia M et al (2002) Nephroblastoma: multidrug-resistance p-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells. Am J Clin Pathol 117:484\u2013490. doi:\n                        10.1309\/L44X-L5DN-1VHV-X30N","journal-title":"Am J Clin Pathol"},{"key":"9549_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00428-007-0401-z","volume":"451","author":"S Fattori","year":"2007","unstructured":"Fattori S, Becherini F, Cianfriglia M et al (2007) Human brain tumors: multidrug-resistance p-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells. Virchows Arch Int J Pathol 451:81\u201387. doi:\n                        10.1007\/s00428-007-0401-z","journal-title":"Virchows Arch Int J Pathol"},{"key":"9549_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1750-3639.2010.00389.x","volume":"20","author":"C Ginguen\u00e9","year":"2010","unstructured":"Ginguen\u00e9 C, Champier J, Maallem S et al (2010) P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) localize in the microvessels forming the blood-tumor barrier in ependymomas. Brain Pathol Zur Switz 20:926\u2013935. doi:\n                        10.1111\/j.1750-3639.2010.00389.x","journal-title":"Brain Pathol Zur Switz"},{"key":"9549_CR23","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ajpath.2011.11.029","volume":"180","author":"K Akiyama","year":"2012","unstructured":"Akiyama K, Ohga N, Hida Y et al (2012) Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment. Am J Pathol 180:1283\u20131293. doi:\n                        10.1016\/j.ajpath.2011.11.029","journal-title":"Am J Pathol"},{"key":"9549_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","volume":"39","author":"SV Ambudkar","year":"1999","unstructured":"Ambudkar SV, Dey S, Hrycyna CA et al (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361\u2013398. doi:\n                        10.1146\/annurev.pharmtox.39.1.361","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9549_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4137\/DTI.S12519","volume":"7","author":"ML Amin","year":"2013","unstructured":"Amin ML (2013) P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights 7:27\u201334. doi:\n                        10.4137\/DTI.S12519","journal-title":"Drug Target Insights"},{"key":"9549_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10456-009-9160-6","volume":"13","author":"KJ Gotink","year":"2010","unstructured":"Gotink KJ, Verheul HMW (2010) Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? Angiogenesis 13:1\u201314. doi:\n                        10.1007\/s10456-009-9160-6","journal-title":"Angiogenesis"},{"key":"9549_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12013-013-9544-5","volume":"67","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang Q (2013) Sunitinib reverse multidrug resistance in gastric cancer cells by modulating Stat3 and inhibiting P-gp function. Cell Biochem Biophys 67:575\u2013581. doi:\n                        10.1007\/s12013-013-9544-5","journal-title":"Cell Biochem Biophys"},{"key":"9549_CR28","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00280-009-0949-1","volume":"64","author":"L-Y Tao","year":"2009","unstructured":"Tao L-Y, Liang Y-J, Wang F et al (2009) Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function. Cancer Chemother Pharmacol 64:961\u2013969. doi:\n                        10.1007\/s00280-009-0949-1","journal-title":"Cancer Chemother Pharmacol"},{"key":"9549_CR29","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/sj.bjc.6603985","volume":"97","author":"Y Mi","year":"2007","unstructured":"Mi Y, Lou L (2007) ZD6474 reverses multidrug resistance by directly inhibiting the function of p-glycoprotein. Br J Cancer 97:934\u2013940. doi:\n                        10.1038\/sj.bjc.6603985","journal-title":"Br J Cancer"},{"key":"9549_CR30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ejps.2012.03.012","volume":"46","author":"C Jovelet","year":"2012","unstructured":"Jovelet C, B\u00e9nard J, Forestier F et al (2012) Inhibition of p-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin. Eur J Pharm Sci Off J Eur Fed Pharm Sci 46:484\u2013491. doi:\n                        10.1016\/j.ejps.2012.03.012","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"key":"9549_CR31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1593\/neo.09866","volume":"11","author":"M Cesca","year":"2009","unstructured":"Cesca M, Frapolli R, Berndt A et al (2009) The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma. Neoplasia N Y N 11:1155\u20131164","journal-title":"Neoplasia N Y N"},{"key":"9549_CR32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ajpath.2014.10.017","volume":"185","author":"K Akiyama","year":"2015","unstructured":"Akiyama K, Maishi N, Ohga N et al (2015) Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel. Am J Pathol 185:572\u2013580. doi:\n                        10.1016\/j.ajpath.2014.10.017","journal-title":"Am J Pathol"},{"key":"9549_CR33","first-page":"127","volume":"78","author":"G Alessandri","year":"1998","unstructured":"Alessandri G, Chirivi RG, Castellani P et al (1998) Isolation and characterization of human tumor-derived capillary endothelial cells: role of oncofetal fibronectin. Lab Investig J Tech Methods Pathol 78:127\u2013128","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"9549_CR34","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nprot.2008.71","volume":"3","author":"JR Beijnum van","year":"2008","unstructured":"van Beijnum JR, Rousch M, Castermans K et al (2008) Isolation of endothelial cells from fresh tissues. Nat Protoc 3:1085\u20131091","journal-title":"Nat Protoc"},{"key":"9549_CR35","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI107470","volume":"52","author":"EA Jaffe","year":"1973","unstructured":"Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745\u20132756. doi:\n                        10.1172\/JCI107470","journal-title":"J Clin Invest"},{"key":"9549_CR36","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1593\/neo.12728","volume":"14","author":"K Bonezzi","year":"2012","unstructured":"Bonezzi K, Belotti D, North BJ et al (2012) Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies. Neoplasia N Y N 14:846\u2013854","journal-title":"Neoplasia N Y N"},{"key":"9549_CR37","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, Aboagye EO, Balkwill F et al (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555\u20131577. doi:\n                        10.1038\/sj.bjc.6605642","journal-title":"Br J Cancer"}],"updated-by":[{"DOI":"10.1007\/s10456-017-9558-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000}}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-017-9549-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-017-9549-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-017-9549-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T08:11:43Z","timestamp":1505808703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-017-9549-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["9549"],"URL":"https:\/\/doi.org\/10.1007\/s10456-017-9549-6","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s10456-017-9558-5","asserted-by":"object"}]},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]}}}